Outlook Therapeutics (OTLK) Capital Leases (2015 - 2022)
Outlook Therapeutics' Capital Leases came in at $1,084 for fiscal Q1 2023 (quarter ended Dec 31, 2022), down 91.8% from $13,221 a year earlier and down 74.6% from the prior quarter.
Powered by 
Analysis
Outlook Therapeutics (OTLK) Capital Leases (2015 - 2022) Analysis & Trends
At the end of FY2022 (ended Sep 30, 2022), Outlook Therapeutics' Capital Leases was $4,267, down 73.4% from FY2021.
- Capital Leases has declined in each of the last four fiscal years, with a five-year compound annual growth rate of -31.4% (FY2017 to FY2022).
- Going back by fiscal year, Capital Leases was $16,018 in FY2021 (-62.3%), $42,482 in FY2020 (-98.7%), $3.37 million in FY2019 (-2.5%) and $3.45 million in FY2018.
- The fiscal Q1 2023 figure represents the lowest quarterly Capital Leases in data going back to fiscal Q4 2015.
- Year-over-year, Capital Leases has declined for 16 consecutive quarters, with an average decline of 72.0% over the last eight quarters.
- The year-over-year decline in Capital Leases has ranged between 1.3% (fiscal Q2 2020) and 99.1% (fiscal Q2 2021) over the last five years.
- Business Quant data shows OTLK's Capital Leases at $4,267 (Q4 2022), $7,349 (Q3 2022) and $10,332 (Q2 2022) in the three fiscal quarters before Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Outlook Therapeutics | 77.94 Mn | 42.19 Mn | -8,265.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 1,084.00 |
| Sep 30, 2022 | 4,267.00 |
| Jun 30, 2022 | 7,349.00 |
| Mar 31, 2022 | 10,332.00 |
| Dec 31, 2021 | 13,221.00 |
| Sep 30, 2021 | 16,018.00 |
| Jun 30, 2021 | 21,703.00 |
| Mar 31, 2021 | 28,755.00 |
| Dec 31, 2020 | 35,682.00 |
| Sep 30, 2020 | 42,482.00 |
| Jun 30, 2020 | 49,162.00 |
| Mar 31, 2020 | 3.35 Mn |
| Dec 31, 2019 | 3.34 Mn |
| Sep 30, 2019 | 3.37 Mn |
| Jun 30, 2019 | 3.35 Mn |
| Mar 31, 2019 | 3.39 Mn |
| Dec 31, 2018 | 3.40 Mn |
| Sep 30, 2018 | 3.45 Mn |
| Jun 30, 2018 | 3.51 Mn |
| Mar 31, 2018 | 3.51 Mn |
API Access
Outlook Therapeutics Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();